T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
T2 Biosystems, a leader in rapid detection of sepsis pathogens and antibiotic resistance genes, will present at the Inaugural Gilmartin Group Emerging Growth Company Showcase on August 31, 2022, at 11:30am ET. Interested parties can access a live webcast through the provided link. Post-event, an archived version will be available on the company's website. T2 Biosystems' innovative products include the T2Dx Instrument and various detection panels powered by proprietary T2 Magnetic Resonance technology, aiming to enhance patient care and reduce treatment costs.
- None.
- None.
LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022, at 11:30am ET.
Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the T2 Biosystems website at https://www.t2biosystems.com/ following the event.
Those parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat™ Panel, the T2Cauris™ Panel, and T2Lyme™ Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406
FAQ
What event is T2 Biosystems presenting at on August 31, 2022?
What time is T2 Biosystems' presentation scheduled for?
How can I watch T2 Biosystems' presentation?
Will T2 Biosystems' presentation be available after the event?
What products does T2 Biosystems offer?
